These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22130385)

  • 21. Schizophrenia patients with and without post-traumatic stress disorder (PTSD) have different mood symptom levels but same cognitive functioning.
    Peleikis DE; Varga M; Sundet K; Lorentzen S; Agartz I; Andreassen OA
    Acta Psychiatr Scand; 2013 Jun; 127(6):455-63. PubMed ID: 23176609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?
    Albus M; Hubmann W; Mohr F; Scherer J; Sobizack N; Franz U; Hecht S; Borrmann M; Wahlheim C
    Schizophr Res; 1997 Nov; 28(1):39-50. PubMed ID: 9428063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological Correlates of Hazard Perception in Older Adults.
    McInerney K; Suhr J
    J Int Neuropsychol Soc; 2016 Mar; 22(3):332-40. PubMed ID: 26708232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?
    McClure MM; Bowie CR; Patterson TL; Heaton RK; Weaver C; Anderson H; Harvey PD
    Schizophr Res; 2007 Jan; 89(1-3):330-8. PubMed ID: 16982175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological and functional correlates of clock-drawing test in elderly institutionalized patients with schizophrenia.
    Okamura A; Kitabayashi Y; Kohigashi M; Shibata K; Ishida T; Narumoto J; Morioka C; Kitabayashi M; Kashima A; Tani N; Nakaaki S; Mimura M; Fukui K
    Psychogeriatrics; 2012 Dec; 12(4):242-7. PubMed ID: 23279146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes in odor identification performance and neuropsychological measures in aging individuals.
    Wehling EI; Wollschlaeger D; Nordin S; Lundervold AJ
    Neuropsychology; 2016 Jan; 30(1):87-97. PubMed ID: 26076320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of treatment utilisation at cognitive remediation groups for schizophrenia: the roles of neuropsychological, psychological and clinical variables.
    Gooding AL; Saperstein A; Rivera Mindt M; Medalia A
    Neuropsychol Rehabil; 2012; 22(4):516-31. PubMed ID: 22390152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.
    Kurtz MM; Donato J; Rose J
    Neuropsychology; 2011 Nov; 25(6):784-791. PubMed ID: 21928906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J; Luppa M; Luck T; Maier W; Wagner M; Daerr M; van den Bussche H; Zimmermann T; Köhler M; Bickel H; Mösch E; Weyerer S; Kaufeler T; Pentzek M; Wiese B; Wollny A; König HH; Riedel-Heller SG
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):84-97. PubMed ID: 22183013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects.
    Ittig S; Studerus E; Papmeyer M; Uttinger M; Koranyi S; Ramyead A; Riecher-Rössler A
    Eur Psychiatry; 2015 Feb; 30(2):242-50. PubMed ID: 25555341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
    Wang LJ; Lin PY; Lee Y; Huang YC; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Hung CF
    Schizophr Res; 2018 Feb; 192():391-397. PubMed ID: 28363347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D; Prikrylova-Kucerova H; Prikryl R; Ceskova E
    Stress; 2016 Jul; 19(4):383-9. PubMed ID: 27320489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between jumping to conclusions and cognitive functioning in people with schizophrenia in contrast with healthy participants.
    Ochoa S; Haro JM; Huerta-Ramos E; Cuevas-Esteban J; Stephan-Otto C; Usall J; Nieto L; Brebion G
    Schizophr Res; 2014 Oct; 159(1):211-7. PubMed ID: 25112159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lowered performance in working memory and attentional sub-processes are most prominent in multi-domain amnestic mild cognitive impairment subtypes.
    Klekociuk SZ; Summers MJ
    Psychogeriatrics; 2014 Mar; 14(1):63-71. PubMed ID: 24528806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.